Tag: Neuroprotective agent

Approved by the FDA in 1995, riluzole was the first drug specifically developed for amyotrophic lateral sclerosis (ALS), with both clinical studies and real-world evidence confirming the significant benefits of taking riluzole tablets, particularly in prolonging patient survival. For those living with ALS, understanding these benefits is crucial for managing the disease's progression.

Cogniza Tablet is a prescription medication used primarily for neurological disorders like stroke, head injury, and Alzheimer's disease. Containing the active ingredient Cerebroprotein Hydrolysate, the use of Cogniza Tablet promotes nerve protection and repair in the brain, improving cognitive functions.

Originally developed in Russia during the late 20th century, Semax is a synthetic peptide created from a fragment of a naturally occurring hormone. Its creation was part of a focused effort to develop treatments for neurological conditions, providing key context for where does Semax come from.